Back to Search Start Over

Nitric oxide-donating derivatives of hederacolchiside A 1 : Synthesis and biological evaluation in vitro and in vivo as potential anticancer agents.

Authors :
Fang Y
Wang R
He M
Huang H
Wang Q
Yang Z
Li Y
Yang S
Jin Y
Source :
Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2017 Jan 01; Vol. 27 (1), pp. 98-101. Date of Electronic Publication: 2016 Nov 10.
Publication Year :
2017

Abstract

A series of nitric oxide (NO) donating derivatives of hederacolchiside A <subscript>1</subscript> bearing triterpenoid saponin motif were designed, synthesized and evaluated for their anticancer activity. All of the tested furoxan-based NO releasing compounds showed significant proliferation inhibitory activities. Especially compound 6a exhibited strong cytotoxicity (IC <subscript>50</subscript> =1.6-6.5μM) against four human tumor cell lines (SMMC-7721, NCI-H460, U251, HCT-116) in vitro and the highest level of NO releasing. Furthermore, compound 6a was revealed low acute toxicity to mice and weak haemolytic activity with potent tumor growth inhibition against mice H22 hepatocellular cells in vivo (51.5%).<br /> (Copyright © 2016 Elsevier Ltd. All rights reserved.)

Details

Language :
English
ISSN :
1464-3405
Volume :
27
Issue :
1
Database :
MEDLINE
Journal :
Bioorganic & medicinal chemistry letters
Publication Type :
Academic Journal
Accession number :
27866816
Full Text :
https://doi.org/10.1016/j.bmcl.2016.11.021